AP2615A - New association between agomelatine and a noradrenaline reuptake inhibitor, and pharmaceutical compositions containing it - Google Patents

New association between agomelatine and a noradrenaline reuptake inhibitor, and pharmaceutical compositions containing it

Info

Publication number
AP2615A
AP2615A AP2008004378A AP2008004378A AP2615A AP 2615 A AP2615 A AP 2615A AP 2008004378 A AP2008004378 A AP 2008004378A AP 2008004378 A AP2008004378 A AP 2008004378A AP 2615 A AP2615 A AP 2615A
Authority
AP
ARIPO
Prior art keywords
agomelatine
pharmaceutical compositions
compositions containing
reuptake inhibitor
noradrenaline reuptake
Prior art date
Application number
AP2008004378A
Other languages
English (en)
Other versions
AP2008004378A0 (en
Inventor
Elisabeth Mocaer
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Servier Lab filed Critical Servier Lab
Publication of AP2008004378A0 publication Critical patent/AP2008004378A0/xx
Application granted granted Critical
Publication of AP2615A publication Critical patent/AP2615A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Dermatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AP2008004378A 2005-09-09 2006-09-08 New association between agomelatine and a noradrenaline reuptake inhibitor, and pharmaceutical compositions containing it AP2615A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0509206A FR2890564B1 (fr) 2005-09-09 2005-09-09 Nouvelle association entre l'agomelatine et un inhibiteur de la recapture de la noradrenaline et les compositions pharmaceutiques qui la contiennent
PCT/FR2006/002067 WO2007028904A1 (fr) 2005-09-09 2006-09-08 Nouvelle association entre l'agomelatine et un inhibiteur de la recapture de la noradrenaline et les compositions pharmaceutiques qui la contiennent

Publications (2)

Publication Number Publication Date
AP2008004378A0 AP2008004378A0 (en) 2008-04-30
AP2615A true AP2615A (en) 2013-03-14

Family

ID=36190808

Family Applications (1)

Application Number Title Priority Date Filing Date
AP2008004378A AP2615A (en) 2005-09-09 2006-09-08 New association between agomelatine and a noradrenaline reuptake inhibitor, and pharmaceutical compositions containing it

Country Status (39)

Country Link
US (1) US7622505B2 (ru)
EP (1) EP1769798B1 (ru)
JP (2) JP5395998B2 (ru)
KR (1) KR100863384B1 (ru)
CN (1) CN1927205A (ru)
AP (1) AP2615A (ru)
AR (1) AR056056A1 (ru)
AT (1) ATE404205T1 (ru)
AU (1) AU2006209368B2 (ru)
BR (1) BRPI0603759A (ru)
CA (1) CA2558782C (ru)
CY (1) CY1108319T1 (ru)
DE (1) DE602006002210D1 (ru)
DK (1) DK1769798T3 (ru)
EA (1) EA011650B1 (ru)
ES (1) ES2313590T3 (ru)
FR (1) FR2890564B1 (ru)
GE (1) GEP20094742B (ru)
GT (1) GT200600408A (ru)
HR (1) HRP20080535T3 (ru)
JO (1) JO2521B1 (ru)
MA (1) MA28505B1 (ru)
ME (2) ME02767B (ru)
MX (1) MXPA06010157A (ru)
MY (1) MY142260A (ru)
NO (1) NO338029B1 (ru)
NZ (1) NZ549725A (ru)
PE (1) PE20070429A1 (ru)
PL (1) PL1769798T3 (ru)
PT (1) PT1769798E (ru)
RS (1) RS50631B (ru)
SA (1) SA06270308B1 (ru)
SG (1) SG131030A1 (ru)
SI (1) SI1769798T1 (ru)
TW (1) TWI324513B (ru)
UA (1) UA83542C2 (ru)
UY (1) UY29778A1 (ru)
WO (1) WO2007028904A1 (ru)
ZA (1) ZA200607562B (ru)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7608737B2 (en) 2007-05-01 2009-10-27 Concert Pharmaceuticasl Inc. Naphthyl(ethyl)acetamides
US20080280991A1 (en) * 2007-05-08 2008-11-13 Auspex Pharmaceuticals, Inc. Substituted naphthalenes
CN102342924A (zh) * 2010-08-05 2012-02-08 北京本草天源药物研究院 一种含有阿戈美拉汀的药物组合物

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005002562A1 (en) * 2003-07-04 2005-01-13 H. Lundbeck A/S The combination of a serotonin reuptake inhibitors and agomelatine

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4843071A (en) * 1986-12-05 1989-06-27 Serotonin Industries Of Charleston Method and composition for treating obesity, drug abuse, and narcolepsy
FR2658818B1 (fr) 1990-02-27 1993-12-31 Adir Cie Nouveaux derives a structure naphtalenique, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
ZA985765B (en) * 1997-07-02 1999-08-04 Merck & Co Inc Polymorphic form of a tachykinin receptor antagonist.
EP0919234A3 (en) * 1997-10-17 1999-08-25 Eli Lilly And Company Potentiation of pharmaceuticals by moxonidine
FR2834890B1 (fr) * 2002-01-23 2004-02-27 Servier Lab Composition pharmaceutique orodispersible d'agomelatine
AU2003213242A1 (en) * 2002-02-26 2003-09-09 Ortho-Mcneil Pharmaceutical Inc. Co-therapy for the treatment of migraine comprising anticonvulsant derivatives and anti-migraine agents
JP2004292445A (ja) * 2003-03-11 2004-10-21 Katsunori Nonogaki 糖尿病治療薬
JP2007505095A (ja) * 2003-09-12 2007-03-08 ワーナー−ランバート カンパニー リミティド ライアビリティー カンパニー うつ病及び不安障害の治療のためのアルファ−２−デルタリガンド及びｓｓｒｉ及び／又はｓｎｒｉを含む組み合わせ

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005002562A1 (en) * 2003-07-04 2005-01-13 H. Lundbeck A/S The combination of a serotonin reuptake inhibitors and agomelatine

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
CHILMAN-BLAIR K ET AL: "AGOMELATINE. ANTIDEPRESSANT TREATMENT OF BIPOLAR DISORDER MELATONIN AGONUST/5-HT20 ANTAGONIST" DRUGS OF THE FUTURE, BARCELONA, ES, vol. 28, no. 1, janvier 2003 (2003-01), pages 7-13, XP009036058 ISSN: 0377-8282 *
FLEISHAKER J C: "CLINICAL PHARMACOKINETICS OF REBOXETINE, A SELECTIVE NOREPINEPHRINE REUPTAKE INHIBITOR FOR THE TREATMENT OF PATIENTS WITH DEPRESSION" CLINICAL PHARMACOKINETICS, LEA & FEBIGER, PHILADELPHIA, PA, US, vol. 39, no. 6, 2000, pages 413-427, XP000991558 *
VERSIANI M: "THE SELECTIVE NORADRENALINE RE-UPTAKE INHIBITOR REBOXETINE HAS AN EARLY ONSET OF ANTIDEPRESSANT ACTION" INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE, MARTIN DUNITZ, LONDON, GB, vol. 4, no. 4, 2000, pages 293-297, XP008039367 ISSN: 1365-1501 *

Also Published As

Publication number Publication date
ME02758B (me) 2010-06-30
AP2008004378A0 (en) 2008-04-30
EP1769798A1 (fr) 2007-04-04
SI1769798T1 (sl) 2008-12-31
ME02767B (me) 2010-06-30
MY142260A (en) 2010-11-15
CA2558782C (fr) 2012-05-15
JP5395998B2 (ja) 2014-01-22
RS50631B (sr) 2010-06-30
MXPA06010157A (es) 2007-03-08
WO2007028904A1 (fr) 2007-03-15
PE20070429A1 (es) 2007-06-02
MA28505B1 (fr) 2007-04-03
AR056056A1 (es) 2007-09-12
JO2521B1 (en) 2010-03-17
TWI324513B (en) 2010-05-11
KR20070029606A (ko) 2007-03-14
DE602006002210D1 (de) 2008-09-25
US7622505B2 (en) 2009-11-24
NO20064048L (no) 2007-03-12
NZ549725A (en) 2008-03-28
TW200744570A (en) 2007-12-16
AU2006209368B2 (en) 2012-07-19
EA011650B1 (ru) 2009-04-28
GEP20094742B (en) 2009-07-27
ZA200607562B (en) 2008-05-28
US20070060654A1 (en) 2007-03-15
DK1769798T3 (da) 2008-11-24
BRPI0603759A (pt) 2007-05-15
FR2890564B1 (fr) 2007-10-19
CN1927205A (zh) 2007-03-14
PL1769798T3 (pl) 2008-12-31
UY29778A1 (es) 2006-10-31
SG131030A1 (en) 2007-04-26
CY1108319T1 (el) 2014-02-12
GT200600408A (es) 2007-05-21
NO338029B1 (no) 2016-07-25
FR2890564A1 (fr) 2007-03-16
UA83542C2 (ru) 2008-07-25
ATE404205T1 (de) 2008-08-15
EP1769798B1 (fr) 2008-08-13
KR100863384B1 (ko) 2008-10-13
EA200601410A1 (ru) 2007-04-27
CA2558782A1 (fr) 2007-03-09
HRP20080535T3 (en) 2008-12-31
JP2011088919A (ja) 2011-05-06
ES2313590T3 (es) 2009-03-01
AU2006209368A1 (en) 2007-03-29
JP2007077147A (ja) 2007-03-29
SA06270308B1 (ar) 2011-10-08
PT1769798E (pt) 2008-09-18

Similar Documents

Publication Publication Date Title
EP1978961A4 (en) MONOAMINE RECORDING INHIBITORS ON TETRALON BASIS
LT1993360T (lt) N-[2,4-bis(1,1-dimetiletil)-5-hidroksifenil]-1,4-dihidro-4-oksochinolin-3-karboksamido kieta forma
IL179371A0 (en) 3-amino-1-arylpropyl indoles as monoamine reuptake inhibitor
HK1121950A1 (en) Stable pharmaceutical composition comprising a pyrimidine-sulfamide
IL188614A0 (en) Highly selective serotonin and norepinephrine dual reuptake inhibitor and use thereof
ZA200802436B (en) Composition comprising a NSAID and paracetamol
EP1941873A4 (en) METALLO-BETA-Lactamase INHIBITORS
IL180557A0 (en) Combination of a selective noradrenaline reuptake inhibitor and a pdev inhibitor
IL166646A0 (en) A new cosmetic composition
IL191477A0 (en) Calcilytic compounds
ZA200803407B (en) Frangrance product, dispenser, and dispenser assembly
EP1921078A4 (en) MULTIKINASE INHIBITOR
AP2006003858A0 (en) New association of a sinus node if inhibitor and acalcium inhibitor, and pharmaceutical composition s containing it
EP2168584A4 (en) PHARMACEUTICAL COMPOSITION COMBINING TRIAZOLOBENZODIAZEPINE AND SELECTIVE SEROTONIN RECAPTURE SELECTIVE INHIBITOR
EP1626950A4 (en) SERTRALINZUSAMMENSETZUNGEN
AP2615A (en) New association between agomelatine and a noradrenaline reuptake inhibitor, and pharmaceutical compositions containing it
EP1728515A4 (en) INHIBITOR OF INFLUENZA VIRUS INFECTION
ZA200607532B (en) Association between agomelatine and a thymoregulatory agent, and pharmaceutical compositions containing it
AU304349S (en) Stamp
AU2003250467A1 (en) Diaryl compounds as monoamine reuptake inhibitors
ZA200804195B (en) Calcilytic compounds
GB0518718D0 (en) A brand specific, service enhancing, gastronome point of sale
GB0522677D0 (en) Polyamine compositions
GB0525015D0 (en) Stamp positioner